Medical Foods Market

Medical Foods Market by Route of Administration (Oral, Enteral), Product (Pills, Powder, and Others [Liquid, Semi-liquid, Semi-solid]), Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy-induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases [Phenylketonuria, Eosinophilic Esophagitis, FPIES, and Others], and Other), Sales Channel (Online Sales, Retail Sales, and Institutional Sales), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021–2028

  • Report ID: FB-628
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 2
  • No. Of Pages: 180
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global medical foods market size was valued at USD 20.15 billion in 2020 and is projected to reach USD 30.34 billion by 2028 expanding at a CAGR of 5.2 % during the forecast period, 2021–2028. The growth of the market is attributed to the increasing prevalence of chronic diseases, rising geriatric population, and increasing awareness of clinical nutrient among healthcare professionals and patients. Due to chronic diseases and type of drug used for treatment patients suffer from nutritional deficiency. Nutritional deficiency is the most common effect after the cancer treatment. Medical foods can help patients to overcome these deficiencies, resulting in market growth.

Medical Foods Market Key Takeaways

Medical food is a food that is prepared to be taken or delivered enterally under the supervision of a physician and is designed for the specialized dietary management of a disease or condition for which particular nutritional requirements are identified by medical evaluation based on recognized scientific principles. Medical foods are not intended for usage by healthy people and should only be consumed under medical supervision. All medical food ingredients must meet the Generally Recognized as Safe (GRAS) standard, which establishes a level of safety based on qualified expert review, published research, and other sources of data. Therefore, to verify efficacy and safety, medical foods have undergone toxicological investigations and several human clinical trials. When a patient's condition requires nutritional nourishment beyond what their normal diet can provide, adding a medical food with its added macro and micronutrients, vitamins, and minerals may be prescribed. Medical foods can occur in several forms, like powders, liquids, and even gum. Some of the diseases for which medical food is prescribed include Alzheimer’s, diabetic neuropathy, nutritional deficiency, and depression.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing prevalence of neurological conditions such as multiple sclerosis, stroke, and dementia and diseases such as Alzheimer’s, diabetic neuropathy, nutritional deficiency, and depression are expected to drive the market growth.
  • Increasing awareness of medical food nutritional benefits is projected to boost the market growth during the forecast period.
  • Increased consciousness in people worldwide about their dietetic care and nutritional support during covid 19 is anticipated to propel the market growth in the coming years.
  • High price of medical food compared to normal food and less availability of medical food are anticipated to restrict the market growth.
  • Lack of awareness related to proper use of medical foods present as key challenges that can hamper the market growth during the forecast period.
  • Increased emphasis on R&D for innovation in medical food and increased expenditure in healthcare by governments in developed economics are projected to create lucrative opportunities for the market players.
  • Increased initiatives by companies such as mergers, acquisitions, product launches to increase awareness regarding medical foods and clinical nutrition is anticipated to create lucrative opportunities for the market players.

Scope of the Report

The report on the global medical foods market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Medical Foods Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Route of Administration (Oral, Enteral), Product (Pills, Powder, and Others [Liquid, Semi-liquid, Semi-solid]), Application (Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy-induced Diarrhea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases [Phenylketonuria, Eosinophilic Esophagitis, FPIES, and Others], and Other), Sales Channel (Online Sales, Retail Sales, and Institutional Sales)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Danone; Nestle; Abbott; Fresenius Kabi; Targeted Medical Pharma; Mead Johnson and Company, LLC.; Medtrition, Inc.; Primus Pharmaceuticals, Inc.


Market Segment Insights

Oral segment is expected to account for a key share of the market
Based on route of administration, the medical foods market is bifurcated into oral and enteral. The oral segment is expected to account for a key share of the market during the forecast period owing to increasing demand for orally consumed medical food and its commercial viability. Powders, tablets, puddings, and pre-thickened products are among the many types of oral supplements available.

On the other hand, the enteral segment is anticipated to expand at a rapid pace during the forecast period owing to increasing prevalence of chronic disorders such as cancer, cardiovascular diseases, and technological advancements enteral feeding devices.

Other segment is expected to constitute a key share of the market
Based on product, the medical foods market is segmented into Pills, Powder, and Others. The other segment is further sub segmented into Liquid, Semi-liquid, Semi-solid. The other segment is expected to constitute a key share of the market during the forecast period owing to increasing application areas of medical food and easy consumption of the product. Liquid based medical food is preferred by geriatric and pediatric populations. Danone's Nutrison Energy, Abbott's Glucerna (Therapeutic Nutrition Shake), and Nestle's Novasource are examples of liquid formulations.

On the other hand, powder segment is anticipated to expand at a rapid pace during the forecast period owing to ease of administration and consumption.

Diabetic neuropathy segment is expected to represent a key share of the market
Based on application, the medical foods market is segmented into chronic kidney disease, minimal hepatic encephalopathy, chemotherapy-induced diarrhea, pathogen related infections, diabetic neuropathy, ADHD, depression, Alzheimer’s disease, nutritional deficiency, orphan diseases, and other. The orphan diseases segment is further segmented into phenylketonuria, eosinophilic esophagitis, FPIES, and others. The diabetic neuropathy segment is expected to represent a key share of the market during the forecast period owing to the increasing prevalence of diabetes and increasing number of people vulnerable to developing some level of neuropathy. Furthermore, the risk of neuropathy rises with age, changes in food, and with unhealthy lifestyle, leading to higher emphasis on nutritional management, which drives market expansion.
On the other hand, chronic kidney disease segment is anticipated to expand at a rapid pace during the forecast period owing to increasing prevalence of kidney disorders specially in geriatric population.

Medical Foods Market By Applications

Institutional sales segment is expected to hold a key share of the market
Based on sales channel, the medical foods market is segmented into online sales, retail sales, and institutional sales. The institutional sales segment is expected to hold a key share of the market during the forecast period owing to increase in demand for these products in inpatient facilities. Medical foods are taken under medical supervision, and enteral and oral products are ingested more at healthcare facilities such as hospitals, clinics, and care centers.

On the other hand, online sales segment is anticipated to expand at a rapid pace during the forecast period owing to increasing prevalence of e-commerce platforms and the convenience offered by these platforms. As e-commerce is becoming more widely used, there is a progressive trend toward online medical food purchases, creating attractive market potential.

Medical Foods Market By Sales Channel

North America is anticipated to dominate the market
On the basis of regions, the medical foods market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market at an impressive CAGR during the forecast period. The regional market growth can be attributed to presence of key players in the market. Furthermore, increasing prevalence of chronic diseases, initiatives by key players and increased adoption of medical food by medical professionals and patients is expected to drive the market growth.

On the other hand, Asia Pacific is expected to exhibit a rapid growth rate in the coming years owing to increasing prevalence of diseases such as diabetes, malnutrition, obesity, cancer, and cardiovascular diseases. Furthermore, the regional market growth may be ascribed to the local presence of key market players such as Abbott, Nestlé, Danone, and Fresenius Kabi, as well as the high income produced by these firms, as well as unexplored prospects in the Asia Pacific area.

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Medical Foods Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Medical Foods Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Medical Foods Market - Supply Chain
  4.5. Global Medical Foods Market Forecast
     4.5.1. Medical Foods Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Medical Foods Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Medical Foods Market Absolute $ Opportunity
5. Global Medical Foods Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Medical Foods Market Size and Volume Forecast by Applications
     5.3.1. Chronic Kidney Disease
     5.3.2. Minimal Hepatic Encephalopathy
     5.3.3. Chemotherapy-induced Diarrhea
     5.3.4. Pathogen Related Infections
     5.3.5. Diabetic Neuropathy
     5.3.6. ADHD
     5.3.7. Depression
     5.3.8. Alzheimer's Disease
     5.3.9. Nutritional Deficiency
     5.3.10. Orphan Diseases
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Medical Foods Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Medical Foods Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Medical Foods Demand Share Forecast, 2019-2026
7. North America Medical Foods Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Medical Foods Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Medical Foods Market Size and Volume Forecast by Applications
     7.4.1. Chronic Kidney Disease
     7.4.2. Minimal Hepatic Encephalopathy
     7.4.3. Chemotherapy-induced Diarrhea
     7.4.4. Pathogen Related Infections
     7.4.5. Diabetic Neuropathy
     7.4.6. ADHD
     7.4.7. Depression
     7.4.8. Alzheimer's Disease
     7.4.9. Nutritional Deficiency
     7.4.10. Orphan Diseases
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Medical Foods Demand Share Forecast, 2019-2026
8. Latin America Medical Foods Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Medical Foods Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Medical Foods Market Size and Volume Forecast by Applications
     8.4.1. Chronic Kidney Disease
     8.4.2. Minimal Hepatic Encephalopathy
     8.4.3. Chemotherapy-induced Diarrhea
     8.4.4. Pathogen Related Infections
     8.4.5. Diabetic Neuropathy
     8.4.6. ADHD
     8.4.7. Depression
     8.4.8. Alzheimer's Disease
     8.4.9. Nutritional Deficiency
     8.4.10. Orphan Diseases
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Medical Foods Demand Share Forecast, 2019-2026
9. Europe Medical Foods Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Medical Foods Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Medical Foods Market Size and Volume Forecast by Applications
     9.4.1. Chronic Kidney Disease
     9.4.2. Minimal Hepatic Encephalopathy
     9.4.3. Chemotherapy-induced Diarrhea
     9.4.4. Pathogen Related Infections
     9.4.5. Diabetic Neuropathy
     9.4.6. ADHD
     9.4.7. Depression
     9.4.8. Alzheimer's Disease
     9.4.9. Nutritional Deficiency
     9.4.10. Orphan Diseases
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Medical Foods Demand Share Forecast, 2019-2026
10. Asia Pacific Medical Foods Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Medical Foods Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Medical Foods Market Size and Volume Forecast by Applications
     10.4.1. Chronic Kidney Disease
     10.4.2. Minimal Hepatic Encephalopathy
     10.4.3. Chemotherapy-induced Diarrhea
     10.4.4. Pathogen Related Infections
     10.4.5. Diabetic Neuropathy
     10.4.6. ADHD
     10.4.7. Depression
     10.4.8. Alzheimer's Disease
     10.4.9. Nutritional Deficiency
     10.4.10. Orphan Diseases
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Medical Foods Demand Share Forecast, 2019-2026
11. Middle East & Africa Medical Foods Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Medical Foods Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Medical Foods Market Size and Volume Forecast by Applications
     11.4.1. Chronic Kidney Disease
     11.4.2. Minimal Hepatic Encephalopathy
     11.4.3. Chemotherapy-induced Diarrhea
     11.4.4. Pathogen Related Infections
     11.4.5. Diabetic Neuropathy
     11.4.6. ADHD
     11.4.7. Depression
     11.4.8. Alzheimer's Disease
     11.4.9. Nutritional Deficiency
     11.4.10. Orphan Diseases
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Medical Foods Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Medical Foods Market: Market Share Analysis
  12.2. Medical Foods Distributors and Customers
  12.3. Medical Foods Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Danone
     12.4.2. Nestle
     12.4.3. Abbott
     12.4.4. Fresenius Kabi
     12.4.5. Targeted Medical Pharma
     12.4.6. Mead Johnson and Company, LLC.
     12.4.7. Medtrition, Inc.
     12.4.8. Primus Pharmaceuticals, Inc.
Segments Covered in the Report
The global medical foods market has been segmented on the basis of

Route of Administration
  • Oral
  • Enteral
Product
  • Pills
  • Powder
  • Others
    • Liquid
    • Semi-liquid
    • Semi-solid
Application
  • Chronic Kidney Disease
  • Minimal Hepatic Encephalopathy
  • Chemotherapy-induced Diarrhea
  • Pathogen Related Infections
  • Diabetic Neuropathy
  • ADHD
  • Depression
  • Alzheimer's Disease
  • Nutritional Deficiency
  • Orphan Diseases
    • Phenylketonuria
    • Eosinophilic Esophagitis
    • FPIES
    • Others
  • Other
Sales Channel
  • Online Sales
  • Retail Sales
  • Institutional Sales
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Danone
  • Nestle
  • Abbott
  • Fresenius Kabi
  • Targeted Medical Pharma
  • Mead Johnson and Company, LLC.
  • Medtrition, Inc.
  • Primus Pharmaceuticals, Inc.

Key players competing in the medical foods market are Danone; Nestle; Abbott; Fresenius Kabi; Targeted Medical Pharma; Mead Johnson and Company, LLC.; Medtrition, Inc.; Primus Pharmaceuticals, Inc.

Medical foods market is highly competitive market. Increased market demand, fueled by increasing acceptability and knowledge of medical foods, is projected to encourage the entry of new companies in the future. Some of the key business strategies are mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase market shares in this market. In February 2020, for example, Fresenius Kabi AG announced a partnership with Vifor Pharma to build a joint venture in China. The goal of this venture is to provide iron deficiency treatment to people in China. This will help the brand get visibility in the Chinese market.

 Medical Foods Market By Key Players

Buy Report